Abstract
Introduction
Endothelial cells serve to regulate the fibrinolytic system in the blood by secreting tissue-type plas-Ž . w x minogen activator t-PA 1 or urokinase-type plas-Ž . w x minogen activator u-PA 2 as well as type-1 plas-Ž .w x minogen activator inhibitor PAI-1 3 . In addition to these fibrinolytic factors in the solution phase, the function of pericellular fibrinolysis has recently been examined. PAI-1 effectively expresses its inhibitory Ž . w x activity on the extracellular matrix ECM 4 . Acti-studies demonstrated that purified t-PAR with mol wt. 40 kDa from endothelial cells is identical to w x annexin II 12 and that both t-PA and plasminogen bind to different binding sites in the molecule, thus exhibiting an enhancement of t-PA-dependent plasw x minogen activation 13 . Another study indicated that t-PA and plasminogen bind to the common binding site on endothelial cells, resulting in competition between t-PA and plasminogen for the cellular bindw x ing site 14,15 . Since u-PAR has only one ligand u-PA in the cell surface fibrinolytic system, the existence of single authentic t-PAR on endothelial cells which recognizes only t-PA but not other components such as plasminogen has been expected.
By employing suspension cultures of human um-Ž . bilical vein endothelial cells HUVEC which do not produce ECM, we have demonstrated t-PAR of mol w x wt. 20 kDa in endothelial cells 16 which specifically interacts with t-PA by forming a complex of mol wt. 90 kDa. Further, the t-PAR was quite different from other t-PA binding molecules such as that from the w x w x placenta 17 or endothelial cells 18 as regards its molecular weight and binding ability to plasminogen. In the present study, we purified t-PAR of mol wt. 20 kDa from HUVEC and analyzed its biological function as a modulator of plasminogen activation by t-PA.
Materials and methods

Materials
Ž Recombinant t-PA from Genentech South San . Francisco, CA was iodinated with 125I by IODO-Ž . GEN Pierce, IL . Aprotinin was obtained from Ž . Mochida Tokyo . Glu-plasminogen was purified from human plasma by Lys-Sepharose column chromatography followed by gel filtration with Sephadex Ž . G-150. Bovine serum albumin BSA and phenyl-Ž . methylsulfonyl fluoride PMSF were from Sigma Ž . Ž . St. Louis, MO . Disuccinimidyl suberate DSS was Ž . from Pierce Rockford, IL . Mouse monoclonal anti-Ž annexin II antibody was from Zymed Lab. Inc. San . Francisco, CA , and two mouse monoclonal antibod-Ž . ies to annexin II light chain clone LC148 and heavy Ž . chain clone CP1-50-5-1 were from Affinity Re-Ž . search Products Ltd. Mamhead . Non-immune IgG was prepared from rabbit serum by protein A-Sepharose and aprotinin-Sepharose column chromatography. All other chemicals were of analytical reagent grade or the highest quality commercially available. . ceut., Osaka . Confluent cells 2.0 = 10 cellsrflask were harvested and the cell pellet was frozen at y808C until use.
Cell culture
Purification of t-PAR
The frozen cell pellet 1.0 = 10 cells was rapidly thawed and lyzed with a lysis buffer consisting of 10 Ž . mM TrisrHCl pH 7.5 containing 0.5 M NaCl, 1 mM PMSF, 100 KIErml aprotinin and 1% Tween Ž . 80. The crude cell extract 2.5 mgrml, 200 ml was subjected to molecular sieving with TSK-3000SW Ž . 21.5 mm ID = 7.5 cm in a high performance liquid Ž . Ž . chromatography HPLC system Tosoh, Tokyo , and Ž . the low mol wt. protein fraction 10-50 kDa was pooled. This fraction was further purified with a Ž . Ž reversed phase column C8 2.1 mm = 30 mm Ap-. plied Biosystems, San Jose, CA employing a linear Ž gradient of acetonitrile 0-70% in 0.1% trifluoro-. acetic acid in a computer-regulated SMART system Ž . Pharmacia LKB Biotechnol, Uppsala . Each peak yielded by the elution was subjected to 125 I-t-PA binding assay on nitrocellulose membrane and SDSPAGErsilver staining, and the peak corresponding to 20 kDa protein with t-PA binding activity was selectively obtained. 
Ligand blotting
Ž
. After the purified t-PAR 2 mgrml was subjected to SDS-PAGE, the protein on the gel was electrically Ž transferred to nitrocellulose membrane Schleicher .
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Ž .
and Schuell . I-t-PA 10 nM or I-plasminogen Ž . 100 mM which had been iodinated by IODO-GEN was reacted with the membrane in phosphate buffered Ž . saline PBS in the presence or absence of 100-fold excess unlabeled t-PA or plasminogen in PBS containing 3% BSA in the presence or absence of an excess amount of unlabeled t-PA at room temperature for 2 hr. After the membrane was rinsed in the buffer, it was subjected to radioautography.
Complex formation of purified t-PAR and t-PA
To examine the capacity of the purified t-PAR to form 90 kDa complex with t-PA, the purified protein Ž .
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Ž . 100 nM was incubated with I-t-PA 25 nM at 48C for 90 min followed by the addition of 5 mM DSS at room temperature for 30 min to cross-link w x these two molecules 16 . The reaction mixture was analyzed by SDS-PAGE followed by radioautography. Other radiolabeled ligand 125 I-plasminogen, 125 Iu-PA or 125 I-BSA were used to examine the cross-linking specificity of the purified t-PAR.
Preparation of t-PAR-coated wells
To immobilize the purified t-PAR onto the plastic Ž . well 96-well multi plate, Sumitomo Bakelite, Osaka , the various concentrations of t-PAR solution in coating buffer containing 0.16% Na CO , 0.3% NaHCO , 2 3 3 Ž . and 0.01% thimerosal pH 9.6 , were added to each well and incubated at 48C overnight. Each well was checked for the amount of coated protein by Cu-Folin method, and the immobilized t-PAR of 0.8, 1.6, 3.3, 6.5, and 13 ngrwell were obtained. After the excess Ž . amount of t-PA 700 ngrml, 50 ml was incubated with each well at 48C or 90 min and then washed, the t-PA protein which bound to each t-PAR-immobi-Ž lized well was measured. BSA-coated wells 0.675, . 1.35, 2.7, 5.4, and 10.7 ngrwell or nude wells were used for the control of the experiments.
Kinetic analysis
To determine the optimal condition for the enhancement of t-PA activity in the presence of soluble form of t-PAR, the plasminogen activation by t-PA Ž . with plasminogen 20 mgrml, 20 ml and chromogenic substrate, D-valyl-leucyl-lysine-p-nitro-Ž . Ž . Ž anilide S-2251 Kabi Vitrum AB, Stockholm 2 . mM, 80 ml was measured by varying molar ratio of Ž t-PA to t-PAR t-PARrt-PA, 0.0625, 0.125, 0.25, . 0.5, 1, 2, 4, 8 and 16 or that of t-PA to BSA Ž . 0.0625-16 . When t-PA was interacted with 4-fold excess mole of t-PAR, the plasminogen activation by t-PA was found to increase maximally. Therefore, the kinetic analysis was performed by reacting the fixed Ž . concentrations of t-PA 22 ngrml, 50 ml and t-PAR Ž . 25 ngrml, 50 ml with varying concentration of Ž . plasminogen 1.25, 2.5, 5, 10 and 20 mgrml, 20 ml Ž . and S-2251 2 mM, 50 ml . Since the binding of t-PA to the immobilized t-PAR with 0.8-13 ngrwell was dose-dependent of the coated protein and saturable, the well with 6.5 ng t-PARrwell was used for the kinetic analysis of plasminogen activation by t-PA bound on the immobilized t-PAR with varying con-Ž centration of plasminogen 1.25, 2.5, 5, 10 and 20 . Ž . m g r ml, 20 ml and S-2251 2 mM, 80 ml . The same amount of free t-PA as immobilized t-PAR-bound Ž . t-PA 22.8 ng was subjected to the assay as the control. The results were analyzed by LineweaverBurk plots to obtain the kinetic constants, K and m k .
cat Binding of plasminogen to immobilized t-PAR Ž was also examined by adding plasminogen 20 . Ž . m g r ml, 20 ml to t-PAR-coated well 6.5 ngrwell at 48C for 90 min. After washing the well with PBS, plasminogen activation was evaluated by reacting ( )Ž . Ž . t-PA 22 ngrml, 50 ml and S-2251 2 mM, 100 ml on the well.
Activities were determined as the increase in absorbance at 405 nm with a microplate reader MTP-120 Ž . Corona Electric, Katsuda .
Effect of monoclonal antibodies to annexin II on the interaction of t-PA and t-PAR
Ž Monoclonal antibodies to annexin II 200 mgrml, . Ž . 50 ml or non-immune IgG 196 mgrml, 50 ml Ž . were mixed with t-PA 22 ngrml, 50 ml , plasmino-Ž . Ž . gen 20 mgrml, 20 ml and S-2251 2 mM, 80 ml to examine the effects of these antibodies on the activation of plasminogen by t-PA in the presence of Ž . soluble t-PAR 25 ngrml, 50 ml . In addition, fol-Ž . lowing incubation of t-PA 400 ngrml, 50 ml in the Ž . Ž t-PAR-coated 6.25 ngrwell or BSA-coated 10.7
. ngrwell wells in the presence or absence of the antibodies at 48C for 90 min, each well was washed with PBS and then subjected to amidolytic assay with Ž . Ž plasminogen 20 mgrml, 20 ml and S-2251 2 mM, . 80 ml .
Results
Purification of 20 kDa protein from endothelial cells
Endothelial cells were lyzed in the buffer consist-Ž . ing of 10 mM TrisrHCl pH 7.5 containing 0.5 M NaCl, 1 mM PMSF, 100 KIErml aprotinin and 1% Tween 80. After insoluble cell debri had been removed by centrifugation, the crude cell extract was subjected to gel filtration with a TSK-3000SW col-Ž . umn in HPLC system For further purification, the low molecular weight protein fraction was concentrated 100-fold and applied to a reversed phase column C8. The reversed phase separation was performed with a linear gradi-Ž . ent of acetonitrile in HPLC system Fig. 1B , and the first peak fraction which was eluted at a concentration of 33% acetonitrile was identified as the single Ž . 20 kDa protein by SDS- PAGE Fig. 2 , lane 3 . The peak fraction was lyophilized and solubilized in 100 Fig. 1 . Purification of t-PAR by gel filtration following by reversed phase separation. Crude cell extract from HUVEC was first subjected to gel filtration by TSK-3000SW column in HPLC Ž . system A . The partially purified t-PAR which was pooled as the low molecular weight proteins was then applied to reversed phase Ž . Ž column C8 and eluted by a linear gradient of acetonitrile max.
. 70% acetonitrile in 0.1% trifluoroacetate in HPLC controlled by Ž . SMART system B . The first peak with retention time at 23 min exhibited the t-PA binding properties. The first peak obtained by the above purification procedures was pooled and lyophilized by Speed Vac to remove the solvent. fied t-PAR lane 8 . Neither I-u-PA nor I-BSA Ž . cross-linked with the t-PAR data, not shoum . About 2.2 mg of the protein was totally recovered from 1.0 = 10 9 cells by these purification procedures.
Assay of plasminogen actiÕation by t-PA in the presence of soluble t-PAR
Plasminogen activation by t-PA was measured in the presence and absence of soluble t-PAR. When t-PA was incubated with increasing concentrations of ( ) Fig. 2 . SDS-PAGE in each step of purification and ligand blot. t-PAR in each step of purification procedure was checked by SDS-PAGErsilver stain. The analytical SDS-PAGE was performed under non-reduced conditions. M, marker proteins with molecular weight masses in kilodaltons indicated on the left; lane 1, crude extract from cells; lane 2, low molecular weight proteins from gel filtration; lane 3, the first peak fraction by reversed Ž .
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phase separation purified t-PAR ; lane 4, I-t-PA ligand blot to the purified t-PAR; lane 5, 125 I-t-PA ligand blot in the presence of 100-fold excess unlabeled t-PA; lane 6, 125 I-plasminogen ligand blot to the purified t-PAR; lane 7, autoradiography of 125 I-t-PA complexed with the purified t-PAR which was chemically cross-linked prior to SDS-PAGE; lane 8, autoradiography of 125 I-plasminogen which was incubated with the purified t-PAR in the presence of DSS prior to SDS-PAGE.
the purified t-PAR in the presence of sufficient amount of plasminogen, plasminogen activation was significantly enhanced in a dose-dependent manner of t-PAR reaching the maximal enhancement of about 12-fold compared with that of t-PA with BSA instead Ž . of t-PAR Fig. 3 . The maximal enhancement of plasminogen activation was observed when t-PA was interacted at least with 4-fold excess t-PAR. As a control for t-PAR, BSA was added to the reaction mixture with plasminogen and t-PA. BSA revealed little or no increase in plasminogen activation activity at any concentration of t-PA examined. Thus, the enhanced plasminogen activation of t-PA by t-PAR was specific, suggesting that t-PAR could modulate the plasminogen activation activity of t-PA.
Assay of plasminogen actiÕation by t-PA bound to immobilized t-PAR
The effect on plasminogen activation of t-PA bound to immobilized t-PAR was examined. After an ecxess amount of t-PA was incubated on various amount of immobilized t-PAR, plasminogen activation was expressed and increased in a dose-dependent manner of the coated protein, indicating that t-PA could bind to the immobilized receptor and exhibit its enzymatic Ž . activity Fig. 4A . The t-PAR-dependent plasminogen activation by t-PA was further demonstrated by the Ž . saturable binding of t-PA Fig. 4B . Plasminogen activation activity was saturable by t-PA which was added with over 25 ngr50 mlrwell on 6.5 ng t-PAR-coated well, and about 22 ng t-PA protein was recovered from the well. Based on their molecular Ž . weights i.e., t-PA as 70 kDa and t-PAR as 20 kDa , 0.314 pmol t-PA could maximally bound to 0.325 pmol t-PAR. Thus, t-PA binds t-PAR with stoichimetrically 1:1 under these concentrations of immobilized t-PAR.
In contrast to the marked plasminogen activation, Fig. 3 . Plasminogen activation activity by t-PA in the presence or absence of soluble t-PAR. Plasminogen activation activity by t-PA in the presence of soluble t-PAR was evaluated by varying Ž the molar ratio between t-PA and t-PAR t-PARrt-PA s1r16-. Ž . Ž . 16 . t-PA 22 ngrml, 50 ml v was incubated with purified Ž . t-PAR solubilized in TrisrHCl buffer 3.92-100 ngrml, 50 ml Ž . Ž. or BSA 1.15-295 ngrml, 50 ml`in 96-well microtiter plate Ž . Ž by adding plasminogen 20 mgrml, 20 ml and S-2251 2 mM, . 80 ml . The plasmin generation was measured at 378C for 180 min and indicated as the increase in absorbance at 405 nm. Values are expressed as the mean value"SD in triplicate measurements.
( )only a slight plasminogen activation was detected when t-PA was added to immobilized BSA. Nonspecific binding of t-PA to the nude well was about 18% of the maximal binding of t-PA to the immobilized t-PAR. Furthermore, binding of plasminogen to immobilized t-PAR was investigated by reacting an excess amount of plasminogen with immobilized t-PAR or immobilized BSA. After incubating plasminogen with these wells, it was examined whether plasminogen could bind to these wells by adding t-PA and S-2251. However, no significant plasminogen activation was observed under these conditions. The above results indicate that t-PA bound specifically to immobilized t-PAR, and that the t-PA bound to t-PAR expressed an effective plasminogen activation activity, while plasminogen did not selectively bind to immobilized t-PAR.
Kinetic analysis of t-PA in the presence of t-PAR
The maximal enhancement of plasminogen activation was obtained when t-PA was interacted with Ž . 4-fold excess soluble t-PAR Fig. 3 . Therefore, ki-Ž netic analysis for plasminogen activation by t-PA 0.3 . Ž nM, 50 ml in the presence of soluble t-PAR 1.2 . Ž . nM, 50 ml or BSA 1.2 nM, 50 ml was performed Ž with varying concentration of plasminogen 16.3-250 . Ž . nM, 20 ml Fig. 5A . K decreaced to 23% and k m cat increased to 340%, resulting in a 34-fold enhancement of enzymatic efficeincy for plasminogen activa-Ž . tion Table 1 . The kinetic parameters of t-PA without any protein were almost the same as those with Ž . BSA data, not shown . Ž After t-PA bound on the immobilized t-PAR 0.3 . pmolrwell , plasminogen activation activity of the Fig. 4 . Activation of plasminogen by t-PAR-bound t-PA. t-PA was incubated with various amounts of purified t-PAR which had been Ž . Ž . Ž . immobilized to the well of microtiter plate A . After the t-PAR-coated wells were incubated with excess t-PA 700 ngrml, 50 ml v at Ž . Ž . 4 8 C for 90 min, the wells were washed and added with plasminogen 20 mgrml, 20 ml and S-2251 2 mM, 80 ml . BSA-coated wells Ž . Ž . 0.68, 1.35, 2.7, 5.4 and 10.7 ngrwell were incubated with t-PA`followed by washing of the well and addition of plasminogen and Ž . Ž .Ž . S-2251 as described above. Immobilized t-PAR 6.5 ngrwell was also incubated with plasminogen 20 mgrml, 50 ml ' which was Ž . Ž . Ž . then washed and added with t-PA 700 ngrml, 50 ml and S-2251 2 mM, 100 ml . Immobilized BSA 10.7 ngrwell was also incubated Ž . with plasminogen^followed by washing of the well and addition of t-PA and S-2251. The same protocols were performed using Ž . protein-non-coated well as a control immobilized protein, 0 ngrwell . The immobilized t-PAR was added with increasing concentration Ž . Ž .Ž . of t-PA B . Plasminogen activation activity was measured as described above on immobilized t-PAR 6.5 ngrwell v , immobilized Ž .Ž . Ž . BSA 10.7 ngrwell`, or nude well^. The activity was determined as the increase in absorbance at 405 nm. Values are expressed as the mean value " SD in triplicate measurements.
Ž . Fig. 5 . Effect of soluble A and immobilized B t-PAR on kinetics of plasminogen activation by t-PA. Plasminogen activa-Ž . tion activity of t-PA 22 ngrml, 50 ml which was incubated Ž . with purified t-PAR 25 ngrml, 50 ml and that of t-PA which Ž . saturablly bound on immobilized t-PAR 6.25 ngrwell were measured by varying concentrations of plasminogen as described in Section 2. The initial rates of plasminogen activation of t-PA Ž .
Ž . Ž . A in the presence of soluble t-PAR v or BSA`, and those Ž . Ž .
Ž . of t-PA B bound on immobilized t-PAR v or in solutionẁ
ere plotted against plasminogen concentration as LineweaverBurk plots.
Ž
. Ž . t-PA 0.3 pmol was efficiently expressed Fig. 5B where K decreased to 44% and k increased to m cat 856%, resulting in a 90-fold enhancement. These Plasminogen activation activity by t-PA was determined by the Ž . amidolysis of S-2251 in the presence of BSA Control-1 or free t-PAR with varying concentration of plasminogen as described in Section 2. Activity of the same amount of t-PA in the fluid phase Ž . as the immobilized t-PAR-bound t-PA was measured Control-2 Ž . and compared with that on the immobilized t-PAR 6.6 ngrwell . a The enhancement of t-PA activity was expressed as a fold-in- results indicate that the enzymatic activity for plasminogen activation by immobilized t-PAR-bound t-PA was further promoted than that in the presence Ž . of soluble t-PAR Table 1 .
From these results, it was concluded that 20 kDa protein is a specific receptor for t-PA and not for plasminogen, and that t-PAR functions as an enhancer of t-PA activity by interacting or binding with t-PA molecule.
Characterization of t-PAR
Since t-PAR of mol wt. 40 kDa from the placenta or endothelial cells was reported to bind to plasminow x gen as well as t-PA 17 and the molecule was w x identified as annexin II 12 , we examined whether or not t-PAR of mol wt. 20 kDa was related to annexin II. As shown in Fig. 6 , the effect of three kinds of mouse monoclonal antibodies to annexin II on plasminogen activation by t-PA in the presence of t-PAR Fig. 6 . Effect of monoclonal antibodies to annexin II on soluble t-PAR-induced enhancement of plasminogen activation by t-PA and on t-PA binding to the immobilized t-PAR. Plasminogen Ž . activation activity of t-PA in the presence lanes 2 to 6 or Ž . Ž . absence lane 1 of soluble t-PAR black bar was measured in the optimal condition as described in Fig. 3, with ( )was examined. In this set of experiment, soluble t-PAR showed about a 10-fold enhancement of the Ž plasminogen activation by t-PA lanes 1 and 2, black . bars . To examine whether or not the purified t-PAR was identical with annexin II or annexin II-related molecules, a panel of monoclonal antibodies to annexin II were employed. When each antibody was added to the reaction mixture of t-PAR, t-PA and plasminogen, the plasminogen activation was not sig-Ž . nificantly changed lanes 3 to 5, black bars as well Ž as that in the presence of non-immune IgG lane 6, . black bar . Furthermore, when t-PA was added to t-PAR-coated wells in the presence or absence of Ž . anti-annexin II antibodies Fig. 6 , plasminogen activation activity by t-PA on immobilized t-PAR was not significantly changed in the presence of anti-an-Ž . nexin II antibodies lanes 3 to 5, hatched bars or Ž . non-immune IgG lane 6, hatched bar , suggesting that the immobilized t-PAR is not composed of such a protein as annexin II or annexin II-related molecule. On the other hand, when t-PA was added to the t-PAR-coated well without these antibodies, about a 6-fold increase in plasminogen activation was ob-Ž . served lane 2, hatched bar as compared to the Ž plasminogen activation in the BSA-coated well lane . 1, hatched bar . In addition, these antibodies did not Ž . alter the activities of t-PA data, not shown . These results suggest that several epitopes which are recognized by a panel of anti-annexin II monoclonal antibodies are not involved in the t-PAR for the enhancement of plasminogen activation of t-PA.
Discussion
The present data support the idea that the cellular fibrinolytic system is regulated by the expression of Ž . t-PA receptor t-PAR in vascular endothelial cells. A major part of the binding of t-PA occurs with PAI-1 w x w x on either the cell surface 21 or the ECM 4 resulting in inhibition of the plasminogen activation by t-PA. On the other hand, the binding of t-PA to the cell surface may enhance plasminogen activation which affords the endothelial cells with antithrombotic properties. The specific receptor for u-PA, u-PAR, has been well characterized, and a pericellular proteolytic system mediated by u-PA has been demonstrated. u-PA immobilized on u-PAR is prew x dominantly involved in cell migration 22 , tissue w x remodeling 23 , and cell invasion, tissue destruction w x and the metastasis of cancer cells 8-10 . Although w x endothelial cells also express u-PAR 11 , the function of the u-PAR in the regulation of intravascular fibrinolysis remains to be identified. Since t-PA is a major activator of plasminogen in the intravascular fibrinolytic system, the event of specific binding of t-PA to endothelilal cells may play a crucial role in the expression of fibrinolytic activity on these cells.
Our previous findings have indicated that the binding of t-PA to endothelial cells was specific and saturable both in suspended cells and in monolayered cells in the presence of anti-PAI-1 IgG. Further, our previous experiments demonstrated that t-PA bound to endothelial cells was recovered as 90 kDa complex from the cell lysates, and that in ligand blot analysis t-PA bound to mol wt. 20 kDa protein which did not w x react with plasminogen 15 .
In the present study, mol wt. 20 kDa protein was purified from human umbilical vein endothelial cells. Detailed analysis revealed that it was quite different from the t-PAR reported previously in terms of w x molecular weight 12,17 and reactivity with plasw x minogen 12,14 .
The binding site of the t-PA molecule to t-PAR was examined. A previous study indicated that the interaction of t-PA with t-PAR was mediated by lysine binding sites, since 5 mM 6-aminohexanoic acid inhibited the binding of radiolabeled t-PA to 20 w x kDa protein 16 . In the present study, t-PA bound to immobilized t-PAR which represents a model system of the cell surface, and the t-PA on the t-PAR Ž enhanced its plasminogen activation activity Fig. 4 . and Table 1 . Since t-PA in the presence of soluble t-PAR enhances its plasminogen activation activity Ž . Fig. 3 , it appears that t-PA may bind to soluble t-PAR in a manner similar to fibrin-or fibrinogen-dew x gradation products 24 . These observations suggest that the binding region of t-PA to t-PAR is not involved in the catalytic domain of t-PA, but possibly kringle domains containing lysine binding sites. Since t-PA formed 90 kDa complex with the purified t-PAR Ž . Fig. 2, lane 7 , it was suggested that t-PA bound to the immobilized t-PAR with stoichimetrically 1:1 and expressed its enzymatic activity more effieciently ( )than t-PA in the fluid phase. In contrast to the immobilized t-PAR, t-PA with 4-fold excess soluble t-PAR exhibited the maximal enhancement of plasminogen activation, indicating that the efficient interaction andror binding between the two molecules could proceed, when the t-PAR exists in its soluble form. The t-PA receptor molecule of mol wt. 40 kDa which was isolated from endothelial cells and identified as annexin II, exhibits a capacity to interact with plasminogen. However, t-PA and plasminogen do not compete in their binding to the t-PAR, implying that t-PA and plasminogen bind to distinct sites in the w x t-PAR molecule 12 . In contrast, t-PA and plasminogen do compete with each other in their binding in a variety of cell lines including endothelial cells, and one of the candidates for plasminogen receptor, a-enolase, also interacts with both plasminogen and t-PA, suggesting that t-PA and plasminogen share a comw x mon binding site on the cells 14 . These receptors thus have a dual function for the binding of the fibrinolytic factors, t-PA and plasminogen. On the other hand, t-PAR which is purified as a mol wt. 20 kDa protein reacts only with t-PA and not with Ž . plasminogen Fig. 2 lanes 4, 7 and 8 . In addition, if plasminogen could bind to the immobilized t-PAR Ž . with low affinity as reported by Hajjar 0.114 mM w x Ž .w x 17 or Miles 2.1 " 1.3 mM 14 , the concentration Ž . of plasminogen added 0.25 mM was considered almost saturable on the immobilized t-PAR so that a significant plasminogen activation would be expected after adding t-PA. However, no significant plasminogen activation was observed, which also indicates that plasminogen did not bind to the 20 kDa-receptor. Though plasminogen competes with t-PA for binding w x to endothelial cells as we previously reported 16 w x and as described by other groups 12,14 , we did not detect any complex formation between plasminogen and the t-PAR on endothelial cells, suggesting that plasminogen did only interfere the binding of t-PA to the t-PAR but did not bind tightly to the t-PAR. The isolated t-PAR also does not bind plasminogen. Therefore, it seems that if plasminogen can interact with the t-PAR, the binding of plasminogen is extrememly lower than that of t-PA, resulting in no complex formation between t-PAR and plasminogen even after cross-linking by DSS. Though the low affinity binding of plasminogen to endothelial cells have been demonstrated as described above, it remains unclear how plasminogen interacts with its Ž . binding site s and whether plasminogen forms such Ž . a stable complex with its binding site s as can be observed by SDS-PAGE.
A single ligand-single receptor system may bring about a specific cellular response by binding of t-PA to t-PAR, although it remains to be determined what kind of signal transduction is induced in endothelial cells by the binding of t-PA to t-PAR.
The t-PAR may function as an enhancing factor of t-PA on the surface of endothelial cells, since exogenously added t-PA exhibited much enhanced plasminogen activation activity in the presence of HU-Ž . VEC data, not shown . Furthermore, t-PA-treated HUVEC showed a significant plasminogen activation indicating that t-PA bound on the cell surface expresses its functional activity, though the inhibition ratio by PAI-1 remains to be studied. Although the authors did not substantially identify the existence of annexin II in HUVEC, anti-annexin II monoclonal antibodies employed in this study partially reduced plasminogen activation by t-PA on HUVEC, suggesting that annexin II may be involved in the expression of t-PA-mediated plasminogen activation on the cell surface. However, excess amount of authentic annexin II derived from fibroblasts did not affect the increase of t-PA activity in the presence of purified Ž . t-PAR data, not shown .
Therefore, based on our findings that a panel of monoclonal antibodies with different epitops to annexin II did not interfere the interaction between t-PA and the 20 kDa-t-PAR and its enhancing potential for Ž . plasminogen activation by t-PA Fig. 6 and that anti-a-enolase IgG did not cross react with the t-PAR w x as previously reported 16 , it is concluded that this molecule is substantially quite different from annexin II and that this novel protein functions as a specific receptor for t-PA and an enhancer of t-PA activity on the surface of endothelial cells.
The possible physiological significance of t-PAR Ž . may be summarized as follows: 1 t-PA is assembled and concentrated on the surface of endothelial cells Ž . by t-PAR; 2 the t-PA on t-PAR expresses its enzymatic activity efficiently, leading to focal plasmino-Ž . gen activation; and 3 these elements afford the endothelial cells with an effective pericellular fibrinolytic activity which contributes to the antithrombotic properties of the endothelium. 
